ALKERMES, INC. for ALKERMES, INC.

Medicare/Medicaid MMM

Maintain six protected classes for depressions and schizophrenia under Medicare Part D Drug pricing issues: HR3 - Lower Drug Costs Now Act; S2543 - Prescription Drug Pricing Reduction Act Medicare Part D Restructuring

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Substance Abuse & Mental Health Services Administration (SAMHSA); Veterans Affairs, Dept of (VA); SENATE; Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 3 (116th)

Alcohol and Drug Abuse ALC

Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings H.J. Res 31, Consolidated Appropriations Act of 2019 (PL 116-6) H.J. Res 28, FY19 Further Additional Continuing Appropriation Act (PL 116-5) S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act HR 6 (PL 115-271) The Support Act funding, including Comprehensive Opioid Recovery Centers

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Justice, Dept of (DOJ); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 3496 (116th), S. 1983 (116th), H.J.Res. 31 (116th), H.R. 6 (116th), H.J.Res. 28 (116th)

Health Issues HCR

Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification HR 6 - SUPPORT for Patient and Communities Act (PL 115-271) PL# 114-198 - 21st Century Cures Opioid implementation Advance the use of and funding for medications to treat serious mental illness Legislation to promote treatment amongst incarcerated individuals with serious mental illness

Contacted: Justice, Dept of (DOJ); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Office of Natl Drug Control Policy (NDCP); Veterans Affairs, Dept of (VA); Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 6 (116th)